Kalbe Farma Tbk PT
IDX:KLBF

Watchlist Manager
Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT
IDX:KLBF
Watchlist
Price: 1 400 IDR 5.26%
Market Cap: 65.6T IDR
Have any thoughts about
Kalbe Farma Tbk PT?
Write Note

Kalbe Farma Tbk PT
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kalbe Farma Tbk PT
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Kalbe Farma Tbk PT
IDX:KLBF
Net Change in Cash
Rp1.5T
CAGR 3-Years
4%
CAGR 5-Years
78%
CAGR 10-Years
15%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Net Change in Cash
Rp305.6B
CAGR 3-Years
-3%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Net Change in Cash
Rp97B
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Soho Global Health Tbk PT
IDX:SOHO
Net Change in Cash
-Rp438.4B
CAGR 3-Years
N/A
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Net Change in Cash
Rp586B
CAGR 3-Years
148%
CAGR 5-Years
505%
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Net Change in Cash
-Rp325.7B
CAGR 3-Years
-54%
CAGR 5-Years
17%
CAGR 10-Years
-36%
No Stocks Found

Kalbe Farma Tbk PT
Glance View

Market Cap
64.6T IDR
Industry
Pharmaceuticals

Kalbe Farma Tbk PT is a renowned pharmaceutical powerhouse rooted in Indonesia, rooted in a rich history that traces back to 1966. The company has evolved from a humble startup into a multifaceted entity with a robust portfolio, making it a vital player in the health and wellness sector across Southeast Asia. The company operates across four main business divisions: prescription pharmaceuticals, consumer health products, nutritionals, and distribution & logistics. By strategically linking these divisions, Kalbe Farma masterfully balances scientific innovation with market accessibility, ensuring a wide reach and varied product offering. This diversification not only broadens its revenue streams but also mitigates risk, securing its foothold in the competitive pharmaceutical landscape. At the core of Kalbe Farma’s business model lies a commitment to research and development, which fuels its cutting-edge product innovations and enhances its competitive edge. The company dedicates substantial resources to developing new medicines and health products, constantly seeking to address emerging health concerns. Moreover, its extensive distribution network fortifies its market presence, comprising a domestic distribution arm that penetrates even the farthest reaches of the Indonesian archipelago. This network ensures that Kalbe's products are widely available, amplifying their market penetration and revenue. Additionally, Kalbe embraces partnerships and collaborations to enhance its research capabilities and expand its product offerings, fostering an ecosystem where innovation and accessibility coexist harmoniously, thereby empowering its bottom line.

KLBF Intrinsic Value
1 429.6 IDR
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Kalbe Farma Tbk PT's Net Change in Cash?
Net Change in Cash
1.5T IDR

Based on the financial report for Sep 30, 2024, Kalbe Farma Tbk PT's Net Change in Cash amounts to 1.5T IDR.

What is Kalbe Farma Tbk PT's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
15%

The average annual Net Change in Cash growth rates for Kalbe Farma Tbk PT have been 4% over the past three years , 78% over the past five years , and 15% over the past ten years .

Back to Top